149 results
Page 5 of 8
8-K
EX-99.1
03b ycrljs6594orvq
15 Mar 19
Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
7:00am
POS AM
55384oxu8qw
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
ddpzyk
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
8-K
EX-99.1
s3sm1 kzg83zcmx
28 Feb 19
Karyopharm Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
7:22am
8-K
EX-99.1
o6jkjn5wh9z8lc2
7 Jan 19
Regulation FD Disclosure
8:26am
8-K
EX-99.1
v9qaxgz 65b2w
3 Dec 18
Other Events
4:06pm
8-K
EX-99.2
38mu3f05cx7
3 Dec 18
Other Events
4:06pm
8-K
EX-99.1
jbi4muod
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
8-K
EX-4.1
6ukjq5 zb
16 Oct 18
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-99.1
tnyoncrlgcy5gepo50ct
11 Oct 18
Other Events
7:17am
8-K
EX-99.1
d5wxke
9 Oct 18
Karyopharm Therapeutics Announces Proposed Private Offering of $150 Million of
4:10pm
8-K
EX-99.1
8gqd9skhtwacdksoq4q
9 Oct 18
Other Events
7:00am
424B5
mxoh75gveu
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
qdf84 yc6n0fr52
7 Aug 18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
7:18am
8-K
EX-99.1
jnen7a2m
6 Aug 18
Other Events
4:17pm
S-3ASR
f56nifx5uz23ctollth
2 Jul 18
Automatic shelf registration
4:08pm